Advertisement
Screener

Spruce Biosciences, Inc. (SPRB) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Spruce Biosciences, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Spruce Biosciences, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $33.33M went out.
  • Fiscal year ended 2025-12-31: from financing, $43.48M came in.
  • Fiscal year ended 2025-12-31: change in cash, $10.15M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$33.33M-$2.06M-$831.00K$5.00K$46.36M*$10.15M
2024-12-31-$55.96M$0.00-$1.62M-$246.00K$180.00K-$57.59M
2023-12-31-$33.27M$55.78M-$1.62M-$311.00K$1.00K$51.07M*$71.64M
2022-12-31-$41.68M$23.69M$0.00$0.00-$40.00K$2.00K-$18.23M
2021-12-31-$35.88M-$79.17M-$4.77M$4.99M$0.00$328.00K-$114.40M
2020-12-31-$27.52M-$74.00K$51.00K$180.98M*$153.44M
2019-12-31-$12.62M-$4.00K$4.49M$7.94M*-$188.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$22.12M*-$135.00K*$0.00*$0.00*$0.00*$64.47M*
2026-03-31-$8.73M-$10.00K$0.00$14.15M-$10.00K$5.17M
2025-12-31-$6.46M*-$841.00K*-$831.00K*$5.00K*$46.36M*
2025-09-30-$5.32M*-$405.00K*$0.00*$0.00*
2025-06-30-$8.83M*$0.00*-$406.00K*$0.00*$0.00*$0.00*
2025-03-31-$12.73M$0.00-$405.00K$0.00$0.00$0.00-$13.14M
2024-12-31-$20.68M*$0.00*-$406.00K*-$233.00K*$0.00*
2024-09-30-$9.22M*$0.00*-$405.00K*$0.00*$0.00*
2024-06-30-$11.11M*$0.00*-$406.00K*-$11.00K*$0.00*
2024-03-31-$14.96M$0.00-$405.00K-$2.00K$180.00K-$15.19M
2023-12-31-$11.21M*$9.30M*-$406.00K*-$217.00K*$1.00K*
2023-09-30-$12.27M*$13.99M*-$405.00K*$0.00*$0.00*
2023-06-30$1.99M*$22.00M*-$406.00K*-$71.00K*$0.00*
2023-03-31-$11.79M$10.48M-$405.00K-$23.00K$0.00$50.96M*$49.22M
2022-12-31-$11.74M*$14.57M*$0.00*$0.00*$0.00*
2022-09-30-$8.58M*-$16.89M*$0.00*-$40.00K*$0.00*
2022-06-30-$9.54M*$33.51M*$0.00*$0.00*$0.00*
2022-03-31-$11.83M-$7.49M$0.00$0.00$2.00K-$19.41M
2021-12-31-$9.80M*-$5.98M*$0.00*$0.00*$0.00*$168.00K*
2021-09-30-$7.60M*-$12.34M*$0.00*$0.00*$17.00K*
2021-06-30-$9.69M*-$60.83M*$0.00*$0.00*$80.00K*
2021-03-31-$8.79M-$19.00K-$4.77M$4.99M$63.00K-$8.52M
2020-12-31-$9.27M*-$24.00K*$0.00*$94.28M*
2020-09-30-$7.60M*-$43.00K*$43.00K*$43.15M*
2020-06-30-$4.70M*
2020-03-31-$5.96M$43.66M*$37.70M
2019-12-31-$2.91M*-$1.00K*$2.00M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
Atrium Therapeutics, Inc. (RNA)United States$0.140B
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Annexon, Inc. (ANNX)United States$0.147B-4.22
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
MEDICINOVA INC (MNOV)United States$0.130B-6.04
IMMUNIC, INC. (IMUX)United States$0.127B-1.88